Danaher Company (NYSE:DHR) BofA Securities 2025 Healthcare Convention Might 15, 2025 1:00 PM ET
Firm Members
Rainer Blair – CEO
Convention Name Members
Mike Ryskin – Financial institution of America
Mike Ryskin
My title is Mike Ryskin. I am on the Financial institution of America Life Science Instruments and Diagnostics group and I am excited to host our subsequent session. We’re joined by Danaher. I am joined by Rainer Blair, CEO. Rainer thanks a lot for being right here.
Rainer Blair
Good morning. Thanks for having us, Mike.
Mike Ryskin
Final session of the convention, however definitely not final however not least, I additionally wish to thank everybody for all of your occasions this week and all of your participation this week. I imply a ton to myself and to the complete BofA group. Actually recognize I hope you discovered the convention useful. We all know that we have now the II vote arising quickly. So I will have 1 plug, I saved it for the final one, so would drastically recognize your assist within the eye vote.
Query-and-Reply Session
Q – Mike Ryskin
However let’s soar in Rainer, wish to get issues off loads of questions on coverage, loads of questions on modifications within the final couple of weeks because you reported 1Q earnings has been definitely busy available in the market. So are you able to give us an replace on kind of a few of the developments over the past couple of weeks, what’s been occurring?
Rainer Blair
Certain. So to begin with, thanks once more for having us. And we’re actually inspired by our robust begin of the yr. We had a pleasant beat right here associated notably to bioprocessing that got here in good and robust, and we upped our full yr information because of that.
And I believe after the primary quarter, as you say, it is
